Parkside Financial Bank & Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.03K | Buy |
53
+8
| +18% | +$910 | ﹤0.01% | 1639 |
|
|
2025
Q1 | $4.73K | Buy |
+45
| New | +$4.73K | ﹤0.01% | 1646 |
|
|
2024
Q4 | – | Sell |
-10
| Closed | -$1K | – | 2163 |
|
|
2024
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1704 |
|
|
2023
Q4 | – | Sell |
-2
| Closed | -$120 | – | 2132 |
|
|
2023
Q3 | $120 | Sell |
2
-48
| -96% | -$2.88K | ﹤0.01% | 2014 |
|
|
2023
Q2 | $3.61K | Hold |
50
| – | – | ﹤0.01% | 1484 |
|
|
2023
Q1 | $3.68K | Hold |
50
| – | – | ﹤0.01% | 1480 |
|
|
2022
Q4 | $3.34K | Sell |
50
-29
| -37% | -$1.94K | ﹤0.01% | 1490 |
|
|
2022
Q3 | $4K | Buy |
79
+13
| +20% | +$658 | ﹤0.01% | 1314 |
|
|
2022
Q2 | $4K | Buy |
66
+61
| +1,220% | +$3.7K | ﹤0.01% | 1345 |
|
|
2022
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1877 |
|
|
2021
Q4 | – | Sell |
-77
| Closed | -$7K | – | 1862 |
|
|
2021
Q3 | $7K | Buy |
+77
| New | +$7K | ﹤0.01% | 1096 |
|
|
2018
Q4 | – | Sell |
-27
| Closed | -$5K | – | 1511 |
|
|
2018
Q3 | $5K | Hold |
27
| – | – | ﹤0.01% | 912 |
|
|
2018
Q2 | $4K | Hold |
27
| – | – | ﹤0.01% | 928 |
|
|
2018
Q1 | $3K | Buy |
27
+6
| +29% | +$667 | ﹤0.01% | 938 |
|
|
2017
Q4 | $2K | Hold |
21
| – | – | ﹤0.01% | 989 |
|
|
2017
Q3 | $2K | Hold |
21
| – | – | ﹤0.01% | 985 |
|
|
2017
Q2 | $2K | Hold |
21
| – | – | ﹤0.01% | 990 |
|
|
2017
Q1 | $1K | Buy |
21
+5
| +31% | +$238 | ﹤0.01% | 1140 |
|
|
2016
Q4 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1133 |
|